Total Payments
$12,159
2024 Payments
$3,456
Companies
41
Transactions
538
Medicare Patients
1,286
Medicare Billing
$160,487
Payment Breakdown by Category
Food & Beverage$11,336 (93.2%)
Travel$724.69 (6.0%)
Education$98.56 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,336 | 533 | 93.2% |
| Travel and Lodging | $724.69 | 3 | 6.0% |
| Education | $98.56 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,423 | 198 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,102 | 52 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $851.52 | 67 | $0 (2024) |
| Echosens North America, Inc. | $762.84 | 4 | $0 (2018) |
| Janssen Biotech, Inc. | $753.85 | 30 | $0 (2024) |
| PFIZER INC. | $651.73 | 23 | $0 (2024) |
| Celgene Corporation | $489.69 | 39 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $407.79 | 11 | $0 (2023) |
| GENZYME CORPORATION | $340.89 | 15 | $0 (2024) |
| Allergan, Inc. | $254.38 | 17 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,456 | 152 | ABBVIE INC. ($1,371) |
| 2023 | $2,272 | 126 | AbbVie Inc. ($958.30) |
| 2022 | $1,812 | 99 | ABBVIE INC. ($590.98) |
| 2021 | $123.29 | 1 | E.R. Squibb & Sons, L.L.C. ($123.29) |
| 2020 | $213.93 | 13 | AbbVie Inc. ($33.86) |
| 2019 | $1,365 | 41 | AbbVie, Inc. ($337.04) |
| 2018 | $1,985 | 69 | Echosens North America, Inc. ($762.84) |
| 2017 | $931.87 | 37 | AbbVie, Inc. ($517.73) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Immunology | ||||||
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | ALBIREO PHARMA, INC. | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 409 | 418 | $359,237 | $47,347 |
| 2022 | 9 | 286 | 308 | $222,397 | $34,887 |
| 2021 | 9 | 259 | 283 | $130,958 | $31,687 |
| 2020 | 11 | 332 | 414 | $170,391 | $46,566 |
Total Patients
1,286
Total Services
1,423
Medicare Billing
$160,487
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 122 | 122 | $153,720 | $12,979 | 8.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 55 | 55 | $71,335 | $12,091 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $31,737 | $8,710 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 48 | $16,560 | $4,987 | 30.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 61 | 63 | $70,119 | $4,393 | 6.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 36 | $8,820 | $2,635 | 29.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $6,946 | $1,552 | 22.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 66 | 67 | $84,420 | $6,848 | 8.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 28 | 28 | $36,316 | $5,548 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $16,092 | $5,283 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 36 | $12,420 | $3,761 | 30.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 35 | 36 | $40,068 | $3,266 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $10,872 | $3,129 | 28.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 18 | $9,252 | $3,067 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 29 | $7,105 | $2,037 | 28.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 22 | $5,852 | $1,948 | 33.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 50 | 50 | $39,500 | $5,226 | 13.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $10,952 | $4,868 | 44.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 25 | $8,425 | $4,350 | 51.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 22 | 22 | $23,452 | $4,318 | 18.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 45 | 45 | $30,690 | $3,613 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 28 | $5,460 | $3,146 | 57.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 31 | $5,239 | $2,782 | 53.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $3,940 | $1,715 | 43.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 25 | $3,300 | $1,669 | 50.6% |
About Eric Chu
Eric Chu is a Gastroenterology healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790879351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Chu has received a total of $12,159 in payments from pharmaceutical and medical device companies, with $3,456 received in 2024. These payments were reported across 538 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,336).
As a Medicare-enrolled provider, Chu has provided services to 1,286 Medicare beneficiaries, totaling 1,423 services with total Medicare billing of $160,487. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Long Beach, CA
- Active Since 10/03/2006
- Last Updated 03/31/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1790879351
Products in Payments
- RINVOQ (Biological) $1,260
- SKYRIZI (Biological) $1,260
- XIFAXAN (Drug) $963.99
- Humira (Biological) $858.94
- Fibroscan (Device) $762.84
- ENTYVIO (Biological) $688.15
- XELJANZ (Drug) $630.88
- ZEPOSIA (Drug) $588.81
- DUPIXENT (Biological) $438.20
- STELARA (Biological) $422.88
- LINZESS (Drug) $289.71
- OCALIVA (Drug) $254.49
- TREMFYA (Drug) $246.83
- Creon (Drug) $235.09
- ZYMFENTRA (Biological) $202.67
- IBSRELA (Drug) $200.71
- ERBE (Device) $178.12
- TRULANCE (Drug) $164.66
- Bravo (Device) $142.23
- OCA (Drug) $138.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Long Beach
Dr. Saeid Goshtasbi, Md, MD
Gastroenterology — Payments: $15,534
Gastroenterology $15,534
Anoop Shah, Md, MD
Gastroenterology — Payments: $14,311
Gastroenterology $14,311
Andrzej Tarnawski, M.d, M.D
Gastroenterology — Payments: $11,760
Gastroenterology $11,760
Dr. Erik Kerekes, M.d, M.D
Gastroenterology — Payments: $10,119
Gastroenterology $10,119
Dr. Seth Miller, Md, MD
Gastroenterology — Payments: $8,889
Gastroenterology $8,889
Peter Sullivan, Md, MD
Gastroenterology — Payments: $3,700
Gastroenterology $3,700